Can you give us a sense for who the patients were that were studied in the LEADER trial? What were some of their baseline characteristics?

Can you give us a sense for who the patients were that were studied in the LEADER trial? What were some of their baseline characteristics?

Can you give us a sense for who the patients were that were studied in the LEADER trial? What were some of their baseline characteristics?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Itamar Raz, MD

Itamar Raz, MD

Professor of Internal Medicine
Head of the Diabetes Unit
Hadassah University Hospital
Jerusalem, Israel